Puma Biotechnology Inc (PBYI)

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Puma Biotechnology Inc Stock (PBYI) Company Profile

Puma Biotechnology Inc

(424) 248-6500

10880 WILSHIRE BLVD., LOS ANGELES, CA

Prossima data di guadagno

Ultimi documenti SEC

PBYI's Discussions on Twitter

Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2021-09-28	Aggiornamento	Citigroup	Neutral → Buy
2020-06-25	Ripresa	BofA/Merrill	Underperform
2019-10-08	Downgrade	Goldman	Neutral → Sell
2019-05-10	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2019-05-10	Downgrade	Citigroup	Buy → Neutral
2019-01-17	Iniziato	Leerink Partners	Mkt Perform
2019-01-03	Downgrade	Guggenheim	Buy → Neutral
2018-11-19	Aggiornamento	Goldman	Sell → Neutral
2018-11-02	Downgrade	BofA/Merrill	Buy → Underperform
2018-11-02	Downgrade	JP Morgan	Neutral → Underweight
2018-10-01	Iniziato	Cantor Fitzgerald	Overweight
2018-09-17	Iniziato	Goldman	Sell
2018-05-11	Reiterato	Stifel	Buy
2017-11-10	Reiterato	Citigroup	Buy
2017-11-10	Reiterato	RBC Capital Mkts	Sector Perform
2017-10-02	Reiterato	Stifel	Buy
2017-09-11	Reiterato	Credit Suisse	Outperform
2017-07-10	Ripresa	Leerink Partners	Outperform
2017-06-06	Reiterato	RBC Capital Mkts	Sector Perform
2017-05-25	Reiterato	RBC Capital Mkts	Sector Perform
2017-03-02	Reiterato	RBC Capital Mkts	Sector Perform

Mostra tutto

Puma Biotechnology Inc Borsa (PBYI) Ultime notizie

Puma Biotechnology Inc Azioni (PBYI) Dati Finanziari

Puma Biotechnology Inc (PBYI)

Puma Biotechnology Inc Stock (PBYI) Company Profile

Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades

Puma Biotechnology Inc Borsa (PBYI) Ultime notizie

Is Puma Biotechnology (NASDAQ:PBYI) A Risky Investment? - Simply Wall St

Puma Biotechnology Inc [NASDAQ: PBYI] Sees Decrease in Stock Value - Knox Daily

Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - sharewise

Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Business Wire

Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Financial Analysis: Puma Biotechnology Inc (PBYI)’s Ratios Unveil Key Insights - The Dwinnex

Was there any good news for Puma Biotechnology Inc (PBYI) stock in the last session? - US Post News

Q1 2026 EPS Estimates for Puma Biotechnology, Inc. Boosted by Analyst (NASDAQ:PBYI) - MarketBeat

Zacks Research Analysts Decrease Earnings Estimates for Puma Biotechnology, Inc. (NASDAQ:PBYI) - MarketBeat

Market Momentum: Puma Biotechnology Inc (PBYI) Registers a 4.33 Increase, Closing at 2.65 - The Dwinnex

Puma Biotech confirms court ruling on patent invalidity, disagrees with verdict - MSN

Lacklustre Performance Is Driving Puma Biotechnology, Inc.'s (NASDAQ:PBYI) 26% Price Drop - Simply Wall St

Puma Biotech patent claims partially invalidated in court - Investing.com

Puma Biotech patent claims partially invalidated in court By Investing.com - Investing.com India

Puma Biotech patent claims partially invalidated in court By Investing.com - Investing.com Australia

Puma Biotech confirms court ruling on patent dispute with AstraZeneca - Seeking Alpha

Puma Biotech drops after patents ruled invalid in fight with AstraZeneca over Tagrisso - MSN

Post-Trade Analysis: Puma Biotechnology Inc (PBYI) Slides -24.79, Closing at 2.71 - The Dwinnex

Puma Biotech drops after patents ruled invalid in fight with AstraZeneca over Tagrisso - Seeking Alpha

Puma Biotechnology, Inc. (NASDAQ:PBYI) Director Michael Patrick Miller Sells 23,358 Shares of Stock - Defense World

Puma Biotechnology, Inc. (NASDAQ:PBYI) Director Sells $81,519.42 in Stock - MarketBeat

Puma Biotechnology director sells over $81k in company stock - Investing.com

Puma Biotechnology director sells over $81k in company stock By Investing.com - Investing.com UK

Puma Biotechnology (NASDAQ:PBYI) Rating Lowered to Buy at StockNews.com - MarketBeat

Puma Biotechnology (NASDAQ:PBYI) Rating Lowered to Buy at StockNews.com - Defense World

Vanguard Group Inc. Reduces Holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World

Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Sold by Vanguard Group Inc. - MarketBeat

Puma Biotechnology's (NASDAQ:PBYI) Earnings Offer More Than Meets The Eye - Yahoo Finance

Puma Biotech prevails in patent suit against AstraZeneca - Investing.com

Puma Biotech prevails in patent suit against AstraZeneca - Investing.com India

Puma Biotech prevails in patent suit against AstraZeneca By Investing.com - Investing.com UK

Puma Biotechnology (NASDAQ:PBYI) Rating Increased to Strong-Buy at StockNews.com - Defense World

Following a 1.5% decline over last year, recent gains may please Puma Biotechnology, Inc. (NASDAQ:PBYI) institutional owners - Simply Wall St

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - StockTitan

Puma Biotechnology (NASDAQ:PBYI) Upgraded by StockNews.com to "Strong-Buy" - MarketBeat

Citigroup upgrades Puma Biotechnology Inc (PBYI) stock to a Buy - Knox Daily

Puma Biotechnology (NASDAQ:PBYI) Issues Earnings Results - Defense World

HC Wainwright Reiterates Buy Rating for Puma Biotechnology (NASDAQ:PBYI) - Defense World

Puma Biotechnology Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Puma Biotechnology (NASDAQ:PBYI) Releases Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

Analysts Have Been Trimming Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target After Its Latest Report - Yahoo Finance

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q2 2024 Earnings Call Transcript - Insider Monkey

Earnings call: Puma Biotechnology reported a total revenue reaching $47.1 million - Investing.com Canada

Earnings call: Puma Biotechnology reported a total revenue reaching $47.1 million - Investing.com UK

Lazard Asset Management LLC Acquires 48,520 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - Defense World

Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected - MSN

Puma Biotechnology (NASDAQ:PBYI) Rating Reiterated by HC Wainwright - MarketBeat

Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected - Yahoo Finance

Analyzing Pacira BioSciences (NASDAQ:PCRX) & Puma Biotechnology (NASDAQ:PBYI) - Defense World

Puma Biotechnology's (PBYI) Q2 Loss Narrower Than Expected - Zacks Investment Research

Puma Biotechnology Inc Azioni (PBYI) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a PBYI